American Scientific Resources Announces Addition of New Board Member

WESTON, Fla., Oct. 22  /PRNewswire-FirstCall/ -- American Scientific Resources, Inc. (Pink Sheets: ASFX), today announced the addition of a new member to the Company's board of directors:  Mr. Jason Roth, the Company's newly appointed Senior Vice-President and Director of Business Development.

Mr. Roth, a successful entrepreneur & marketing specialist in the medical supply industry, has taken great strides to advance the Company's brand and provide for an additional revenue channel by introducing the world's only FDA approved home needle destruction device, the Disintegrator Plus(TM), to ASR who acquired the exclusive selling and intellectual property rights from Safeguard Medical Technologies LLC.

Dr. Christopher F. Tirotta, CEO for American Scientific commented, "We are pleased to welcome Jason to the Board and look forward to seeing the results derived from his contacts and expertise."

About American Scientific Resources, Inc.

American Scientific Resources, Inc. is the parent company for wholly-owned subsidiaries, Kidz-Med and Heart Smart System. The Company's objective is to locate and acquire innovative health and safety products that are successfully sold abroad, and to introduce and promote them to the North American market. More information about the Company, including financial information, can be found on the ASFX web site at http://www.americansci.com/.  For product information, visit the Company's subsidiary, Kidz-Med at http://www.kidzmed.com/.

Safe Harbor

This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.

  Contact:
  Ronald Garner
  Investor Hotline:
  619-293-0621
  

DATASOURCE: American Scientific Resources, Inc.



CONTACT:  Ronald Garner, Investor Hotline: [phone],





Web Site:  http://www.americansci.com/ 

Copyright